Greenamyre J T
Arch Neurol. 1986 Oct;43(10):1058-63. doi: 10.1001/archneur.1986.00520100062016.
Glutamate is the putative neurotransmitter of several clinically important pathways, including cortical association fibers, corticofugal pathways such as the pyramidal tract, and hippocampal, cerebellar, and spinal cord pathways. The excitatory actions of glutamate are mediated by multiple, distinct receptor types and potent receptor antagonists have recently been developed. Glutamate also has neurotoxic properties and can produce "excitotoxic" lesions reminiscent of human neurodegenerative disorders. Abnormally enhanced glutamatergic neurotransmission may cause excitotoxic cell damage and lead to the neuronal death associated with olivopontocerebellar atrophy, Huntington's disease, status epilepticus, hypoxia/ischemia, and hypoglycemia. Pharmacologic manipulation of the glutamatergic system may have great potential for the rational treatment of a variety of neurologic diseases.
谷氨酸是几种临床重要神经通路的假定神经递质,包括皮质联合纤维、锥体束等皮质传出通路,以及海马、小脑和脊髓通路。谷氨酸的兴奋作用由多种不同的受体类型介导,最近已开发出有效的受体拮抗剂。谷氨酸还具有神经毒性特性,可产生类似于人类神经退行性疾病的“兴奋性毒性”损伤。谷氨酸能神经传递异常增强可能导致兴奋性毒性细胞损伤,并导致与橄榄体脑桥小脑萎缩、亨廷顿舞蹈病、癫痫持续状态、缺氧/缺血和低血糖相关的神经元死亡。对谷氨酸能系统进行药物调控可能对合理治疗多种神经系统疾病具有巨大潜力。